Selective kappa opioid receptor agonist could dial out side effects

In a study published in Cell, researchers at the University of North Carolina at Chapel Hill and colleagues solved the crystal structure of the kappa opioid receptor (KOR; OPRK1) bound to

Read the full 317 word article

User Sign In